CVRx operates in the specialized medical device and cardiovascular neuromodulation landscape, where it develops therapies for heart failure and resistant hypertension. While it occupies a unique therapeutic niche with its proprietary baroreflex activation technology, its broader competitive environment includes major medical device manufacturers and cardiac rhythm management companies that produce alternative heart failure solutions, such as Medtronic, Abbott Laboratories, Boston Scientific, and Edwards Lifesciences.